Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001076809-20-000321
Filing Date
2020-12-10
Accepted
2020-12-10 19:34:34
Documents
1
Period of Report
2020-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3571
  Complete submission text file 0001076809-20-000321.txt   5536
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Reporting) CIK: 0001076809 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-38634 | Film No.: 201381839

Mailing Address 250 WEST 55TH ST SUITE 30A NEW YORK NY 10019
Business Address
GLAZER PAUL J (Reporting) CIK: 0001133985 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38634 | Film No.: 201381838

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
Tenzing Acquisition Corp. (Issuer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0228
SIC: 2834 Pharmaceutical Preparations